Alkermes, Inc.
-
Ticker
ALKS
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Dublin, Ireland
Alkermes, Inc., an integrated biotechnology company, provides extended-release injectable and oral products for the treatment of prevalent and chronic diseases, such as central nervous system disorders, reward disorders, addiction, diabetes, and autoimmune disorders.
REPORT RATINGS
4.8 / 5.0 (320)
Alkermes, Inc. reports have an aggregate usefulness score of 4.8 based on 320 reviews.
Alkermes, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
View 2023 Corporate Responsibility Report
Older/Archived Annual Reports